Husky Research Corporation Inc - Medicare Audiologist in Bloomsburg, PA

Husky Research Corporation Inc is a medicare enrolled "Audiologist" provider in Bloomsburg, Pennsylvania. Their current practice location is 400 E 2nd St, Bloomsburg University Centennial Hall, Bloomsburg, Pennsylvania. You can reach out to their office (for appointments etc.) via phone at (570) 389-5380.

Husky Research Corporation Inc is licensed to practice in Pennsylvania (license number D00617) and it also participates in the medicare program. Husky Research Corporation Inc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1518040179.

Contact Information

Husky Research Corporation Inc
400 E 2nd St, Bloomsburg University Centennial Hall,
Bloomsburg, PA 17815-1301
(570) 389-5380
(570) 389-5022



Healthcare Provider's Profile

Full NameHusky Research Corporation Inc
TypeFacility
SpecialityAudiologist
Location400 E 2nd St, Bloomsburg, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1518040179
  • Provider Enumeration Date: 10/24/2006
  • Last Update Date: 02/23/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 2062498967
  • Enrollment ID: O20040629001153

Medical Identifiers

Medical identifiers for Husky Research Corporation Inc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1518040179NPI-NPPES
50218OtherPAGEISINGER HEALTH PLAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
231H00000XAudiologist D00617 (Pennsylvania)Primary
231HA2500XAudiologist - Assistive Technology Supplier D0061700 (Pennsylvania)Secondary
235Z00000XSpeech-language Pathologist (* (Not Available))Secondary
237600000XAudiologist-hearing Aid Fitter D0061700 (Pennsylvania)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Husky Research Corporation Inc acts as a billing entity for following providers:
Provider NameDeborah R John
Provider TypePractitioner - Qualified Audiologist
Provider IdentifiersNPI Number: 1114000510
PECOS PAC ID: 4688650518
Enrollment ID: I20040629001375

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Provider NameThomas R Zalewski
Provider TypePractitioner - Qualified Audiologist
Provider IdentifiersNPI Number: 1063628444
PECOS PAC ID: 0749266690
Enrollment ID: I20040629001489

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Provider NameAmanda Weremedic
Provider TypePractitioner - Qualified Audiologist
Provider IdentifiersNPI Number: 1093902157
PECOS PAC ID: 2961590625
Enrollment ID: I20071113000510

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Provider NameKerry T Ridall
Provider TypePractitioner - Qualified Speech Language Pathologist
Provider IdentifiersNPI Number: 1548576713
PECOS PAC ID: 9436315728
Enrollment ID: I20120801000377

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Provider NameKailyn Stewart
Provider TypePractitioner - Qualified Speech Language Pathologist
Provider IdentifiersNPI Number: 1750830881
PECOS PAC ID: 4880974310
Enrollment ID: I20161129001826

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Provider NameBecca Petrone
Provider TypePractitioner - Qualified Speech Language Pathologist
Provider IdentifiersNPI Number: 1700331881
PECOS PAC ID: 2163791286
Enrollment ID: I20170706000164

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Provider NameDanielle N Huss
Provider TypePractitioner - Qualified Speech Language Pathologist
Provider IdentifiersNPI Number: 1962857771
PECOS PAC ID: 9133454549
Enrollment ID: I20190708001797

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Husky Research Corporation Inc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Husky Research Corporation Inc
400 E 2nd St, Bloomsburg University Centennial Hall,
Bloomsburg, PA 17815-1301

Ph: (570) 389-5380
Husky Research Corporation Inc
400 E 2nd St, Bloomsburg University Centennial Hall,
Bloomsburg, PA 17815-1301

Ph: (570) 389-5380

News Archive

Geron's hESC derived GRNCM1 halts remodeling process and preserves cardiac function in acute heart damage

Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.

Markey's cancer researcher wins NIH's New Innovator Award

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

H. pylori bacterium produces urease to neutralize gastric acid

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive.

Active strategy of detecting and treating asymptomatic MSAD results in no clinical benefit

In patients with high-risk coronary artery disease (CAD), an active strategy of detecting and treating asymptomatic multisite artery disease (MSAD) combined with intensive medical therapy did not improve 2-year outcomes compared to a more traditional approach of managing only symptomatic coronary and extracoronary lesions, new research shows.

Read more News

› Verified 3 days ago


Audiologist in Bloomsburg, PA

Dr. Thomas R Zalewski, PH.D.
Audiologist
Medicare: Medicare Enrolled
Practice Location: 400 E 2nd St, Bloomsburg University, Bloomsburg, PA 17815
Phone: 570-389-5380    Fax: 570-389-5022
Dr. Amanda Marie Weremedic, AU.D.
Audiologist
Medicare: Accepting Medicare Assignments
Practice Location: 400 E 2nd St, Centennial Hall Room 338, Bloomsburg, PA 17815
Phone: 570-389-5380    Fax: 570-389-5022
Deborah R John, AU.D.
Audiologist
Medicare: Accepting Medicare Assignments
Practice Location: 400 E 2nd St, Centennial Hall, Bloomsburg, PA 17815
Phone: 570-389-5380    Fax: 570-389-5022
Mrs. Sandra J. Mcginley, M.S., CCC-A
Audiologist
Medicare: Accepting Medicare Assignments
Practice Location: 6850 Lows Rd, Suite 320, Bloomsburg, PA 17815
Phone: 570-387-4368    Fax: 570-387-6344
Carly Magill,
Audiologist
Medicare: Accepting Medicare Assignments
Practice Location: 6850 Lows Rd Ste 320, Suite 204205, Bloomsburg, PA 17815
Phone: 570-387-4368    
Christi Lynn Moncavage, AU.D.
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 400 E 2nd St, Centennial Hall, Bloomsburg, PA 17815
Phone: 570-389-5380    Fax: 570-389-5022
Richard M Angelo, PH.D.
Audiologist
Medicare: Not Enrolled in Medicare
Practice Location: 400 E 2nd St, Centennial Hall, Bloomsburg, PA 17815
Phone: 570-389-5380    Fax: 570-389-5022

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.